Harel Insurance Investments & Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $565K | Buy |
1,270
+504
| +66% | +$224K | 0.01% | 216 |
|
|
2025
Q1 | $371K | Sell |
766
-140
| -15% | -$67.8K | ﹤0.01% | 234 |
|
|
2024
Q4 | $365K | Sell |
906
-4,259
| -82% | -$1.72M | 0.01% | 170 |
|
|
2024
Q3 | $2.4M | Sell |
5,165
-6,777
| -57% | -$3.15M | 0.04% | 119 |
|
|
2024
Q2 | $5.63M | Buy |
11,942
+432
| +4% | +$203K | 0.11% | 72 |
|
|
2024
Q1 | $4.81M | Buy |
11,510
+1,412
| +14% | +$590K | 0.09% | 77 |
|
|
2023
Q4 | $4.12M | Buy |
10,098
+4,758
| +89% | +$1.94M | 0.07% | 95 |
|
|
2023
Q3 | $1.88M | Sell |
5,340
-4,918
| -48% | -$1.73M | 0.04% | 134 |
|
|
2023
Q2 | $3.57M | Buy |
10,258
+7,023
| +217% | +$2.45M | 0.09% | 72 |
|
|
2023
Q1 | $1.01M | Buy |
3,235
+669
| +26% | +$209K | 0.02% | 173 |
|
|
2022
Q4 | $740K | Sell |
2,566
-136
| -5% | -$39.2K | 0.02% | 174 |
|
|
2022
Q3 | $791K | Buy |
2,702
+2,301
| +574% | +$674K | 0.02% | 175 |
|
|
2022
Q2 | $113K | Buy |
401
+52
| +15% | +$14.7K | ﹤0.01% | 391 |
|
|
2022
Q1 | $91K | Buy |
+349
| New | +$91K | ﹤0.01% | 451 |
|
|
2021
Q3 | – | Sell |
-578
| Closed | -$380K | – | 811 |
|
|
2021
Q2 | $380K | Sell |
578
-291
| -33% | -$191K | 0.01% | 510 |
|
|
2021
Q1 | $624K | Sell |
869
-3,099
| -78% | -$2.23M | 0.01% | 468 |
|
|
2020
Q4 | $3.02M | Buy |
3,968
+604
| +18% | +$459K | 0.07% | 133 |
|
|
2020
Q3 | $915K | Buy |
3,364
+2,664
| +381% | +$725K | 0.03% | 132 |
|
|
2020
Q2 | $203K | Buy |
+700
| New | +$203K | 0.01% | 249 |
|
|
2017
Q1 | – | Sell |
-48
| Closed | -$4K | – | 489 |
|
|
2016
Q4 | $4K | Sell |
48
-490
| -91% | -$40.8K | ﹤0.01% | 347 |
|
|
2016
Q3 | $47K | Sell |
538
-132
| -20% | -$11.5K | 0.01% | 228 |
|
|
2016
Q2 | $58K | Sell |
670
-160
| -19% | -$13.9K | 0.01% | 322 |
|
|
2016
Q1 | $66K | Sell |
830
-453
| -35% | -$36K | 0.01% | 186 |
|
|
2015
Q4 | $161K | Buy |
+1,283
| New | +$161K | 0.02% | 116 |
|